Blackstone Invests $125 Million in NantPharma, a NantWorks Company
California-based NantWorks, LLC, announced today that leading investment firm Blackstone (NYSE: BX) has invested US$125 million in NantPharma. NantPharma operates a number of drug manufacturing and research facilities around the country. In January 2012, it announced the acquisition and redevelopment of a former Pfizer facility in Terre Haute, Indiana, with a commitment to invest $85.5 million to produce critical care injectable and oncological drugs. The new plant is expected to become operational in 2015.
(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.